AGI Dermatics - Business Strategy

Business Strategy

AGI Dermatics has made the Long Island Technology Fast 50 for 7 consecutive years. The Long Island Technology Fast 50 is a ranking of the 50 fastest-growing companies in the area by Deloitte & Touche USA LLP.

Download Company Fact Sheet

See AGI Dermatics at work. Watch our video: Windows Media Quicktime

Revolution in Skin Care

AGI Dermatics is at the leading edge of two trends in the skin care field:

The first trend is the convergence of dermatology and cosmetics. Dermatologists are increasingly concerned with cosmetic treatments, including surgery, injections and topicals. Cosmetic and personal care companies are creating new products that produce visible results in consumers. This convergence creates a demand for high technology ingredients, sophisticated clinical testing, and the ability to explain science to the consumer.
The second trend is the demand for anti-aging and sun protection products for the aging population. It is anticipated that the number of people over the age of 60 will triple in the U.S. by the year 2050.

Core Value

AGI Dermatics' core value is the translation of the latest scientific research in dermatology into skin care, and especially sun care, products. The company creates value through the discovery, development and explanation of technical concepts for the marketplace.

Intellectual Property and Technology Base

AGI Dermatics holds a portfolio of over two dozen patents and applications covering DNA repair enzyme technology, skin therapy and liposome dermatics, forming a strong technology platform. The broadest U.S. patent covers biologically active proteins in liposomes delivered into cells of the skin.

The company conducts world-class skin photobiology research, regularly publishes scientific papers, presents its data at U.S. and international conferences, and is widely recognized for its breakthrough research.